Compile Data Set for Download or QSAR
Found 76 Enz. Inhib. hit(s) with all data for entry = 7555
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202238(US9238619, 3)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202348(US9238619, 67)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202240(US9238619, 5)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202241(US9238619, 6)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202247(US9238619, 10)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202249(US9238619, 12)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202260(US9238619, 18)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202265(US9238619, 23)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202266(US9238619, 24)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202271(US9238619, 29)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202272(US9238619, 30)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202274(US9238619, 32)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202275(US9238619, 33)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202316(US9238619, 52)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202334(US9238619, 59)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202336(US9238619, 61)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202337(US9238619, 62)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202351(US9238619, 70)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202353(US9238619, 72)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202356(US9238619, 73)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202358(US9238619, 75)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202359(US9238619, 76)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202361(US9238619, 78)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202314(US9238619, 50)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202270(US9238619, 28)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202273(US9238619, 31)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202315(US9238619, 51)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202335(US9238619, 60)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202341(US9238619, 63)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202239(US9238619, 4)copy SMILEScopy InChI
Affinity DataKi: <0.100nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202230(US9238619, 1)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202237(US9238619, 2)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202242(US9238619, 7)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202245(US9238619, 8)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202246(US9238619, 9)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202248(US9238619, 11)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202261(US9238619, 19)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202263(US9238619, 21)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202267(US9238619, 25)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202268(US9238619, 26)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202269(US9238619, 27)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202281(US9238619, 35)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202282(US9238619, 36)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202312(US9238619, 48)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202322(US9238619, 53)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202327(US9238619, 55)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202328(US9238619, 56)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202333(US9238619, 58)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202349(US9238619, 68)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
TargetSodium- and chloride-dependent glycine transporter 1(Homo sapiens (Human))
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.

US Patent
LigandPNGBDBM202350(US9238619, 69)copy SMILEScopy InChI
Affinity DataKi: <1nMAssay Description:Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5T6FUS Patent
Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: